Spine-Tech (SPYN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Spine-Tech (SPYN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: .com who wrote (63)	9/23/1996 2:30:00 PM
From: Tom Nguyen	of 242

Wow - great news on the approval front. I also read another news clipping where the CEO said he was very comfortable with the higher end revenues and earnings estimate... will post it later.. however, he also indicated that this quarter's loss could be greater than the .06c estimate.. so you might want to wait till after to buy in. Though he did mention that he could be wrong and orders could come in so quickly that they might have a breakeven quarter. With next year's estimate at about .75 for the high end, PE on '97 earnings would be about 30.. anyone have any longterm growth prospects? what about problem with competitors coming to market? though the early approval really does give SPYN big advantage over US surgical.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next